US stock · Healthcare sector · Medical Care Facilities
A
Amedisys, Inc.
AMED
NASDAQ71.00
USD
+1.21
(+1.73%)
Market Closed
23.24P/E
15Forward P/E
1.10P/E to S&P500
2.311BMarket CAP
- -Div Yield
Upcoming Earnings
25 Apr-1 May
Shares Short
3/15/23
1.8M
Short % of Float
6.38%
Short % of Shares Outs.
5.54%
% Held by Insiders
1.97%
% Held by Institutions
98.08%
Beta
1.04
PEG Ratio
-4.49
52w. high/low
179.91/69.36
Avg. Daily Volume
0.43M
Return %
Stock
S&P 500
1 year
(45.52)
(9.05)
3 years
(47.90)
50.26
5 years
32.55
38.50
Scale: |
High
Low
67.98
33.27
53.30
25.20
64.28
22.82
38.87
9.12
15.95
9.35
18.70
8.81
30.48
12.86
48.34
24.81
55.16
31.16
65.91
42.05
140.91
49.80
168.14
106.65
298.54
134.54
325.12
133.62
179.91
79.48
106.02
79.30
Currency: USD
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Revenue per share
27.01
44.90
55.58
58.30
51.24
49.77
39.98
37.29
38.78
43.30
45.50
50.70
60.84
63.62
68.00
68.28
Earnings per share
2.52
3.28
4.99
4.02
(13.33)
(2.80)
(3.08)
0.40
(0.09)
1.12
0.90
3.64
3.95
5.64
6.42
3.64
FCF per share
2.49
4.45
7.57
4.99
3.39
0.71
1.94
(2.40)
2.62
1.40
2.82
6.62
6.04
8.71
5.61
3.90
Dividends per share
- -
- -
- -
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
CAPEX per share
1.11
1.25
1.53
2.37
1.55
1.61
1.34
0.37
0.65
0.47
0.32
0.20
0.25
0.16
0.19
0.19
Book Value per sh.
17.30
21.23
27.00
31.32
18.08
15.13
11.91
12.30
12.40
13.86
15.29
14.69
19.93
24.85
28.61
32.30
Comm.Shares outs.
26
26
27
28
29
30
31
32
33
33
34
33
32
33
33
33
Avg. annual P/E ratio
14.7
14.8
7.7
10.4
(1.8)
(4.5)
(4.4)
47.9
(387.0)
40.2
58.6
24.5
33.0
37.5
35.6
33.3
P/E to S&P500
0.8
0.7
0.1
0.5
(0.1)
(0.3)
(0.3)
2.6
(19.3)
1.8
2.5
1.0
1.4
1.0
1.2
1.6
Avg. annual div. yield
- -
- -
- -
0.0%
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue (m)
698
1,187
1,513
1,634
1,470
1,488
1,249
1,205
1,281
1,437
1,534
1,663
1,956
2,072
2,214
2,223
Operating margin
13.8%
13.2%
15.2%
11.8%
(32.0)%
(7.5)%
(12.4)%
2.0%
(0.7)%
4.0%
5.1%
9.3%
9.1%
10.6%
11.4%
8.1%
Depreciation (m)
14
20
28
35
40
40
37
28
20
20
17
13
54
68
71
0
Net profit (m)
65
87
136
113
(382)
(84)
(96)
13
(3)
37
30
119
127
184
209
119
Income tax rate
37.0%
38.7%
38.7%
39.0%
21.6%
18.0%
38.3%
36.6%
(650.6)%
38.9%
62.0%
24.4%
24.9%
12.2%
25.0%
26.6%
Net profit margin
9.3%
7.3%
9.0%
6.9%
(26.0)%
(5.6)%
(7.7)%
1.1%
(0.2)%
2.6%
2.0%
7.2%
6.5%
8.9%
9.4%
5.3%
Working capital (m)
63
(10)
(11)
78
10
1
(107)
(27)
0
34
96
2
24
(94)
(18)
33
Long-term debt (m)
13
- -
- -
- -
- -
67
33
104
95
88
78
6
231
266
501
494
Equity (m)
447
561
735
878
519
452
372
397
410
460
515
482
640
809
931
1,052
ROIC
13.4%
11.2%
15.2%
11.0%
(58.9)%
(14.5)%
(22.5)%
3.6%
14.4%
7.4%
5.4%
25.3%
14.8%
17.4%
15.1%
8.6%
Return on capital
17.6%
14.8%
20.0%
15.0%
(55.7)%
(12.7)%
(20.7)%
4.3%
1.4%
9.1%
10.5%
23.1%
14.6%
14.1%
15.9%
9.5%
Return on equity
14.6%
15.4%
18.5%
12.8%
(73.7)%
(18.5)%
(25.8)%
3.2%
(0.7)%
8.1%
5.9%
24.8%
19.8%
22.7%
22.4%
11.3%
Plowback ratio
100.0%
100.0%
100.0%
99.7%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Div.&Repurch./FCF
(9.8)%
(3.2)%
(2.6)%
4.2%
- -
- -
- -
- -
- -
26.5%
7.3%
86.7%
4.9%
19.2%
64.0%
13.6%
Capital Structure
16 Feb · 2023 | Q4
All numbers in millions
Total liabilities
$ 870
Total assets
$ 1,976
Long-term debt
$ 494
Cash and equiv.
$ 41
Goodwill
$ 1,287
Retained earnings
$ 758
Common stock
32
Enterprise Value
$ 2,764
Working Capital
Currency: USD, in millions
2020
2021
2022
Cash & Investments
82
43
41
Receivables
264
275
297
Inventory
- -
- -
- -
Other
16
(0)
10
Current assets
362
357
389
Acc. Payable
43
38
44
Debt due
41
44
49
Other
373
292
263
Current liabilities
456
374
356
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
0.41%
7.71%
6.77%
Cash flow
(30.38)%
(7.60)%
(31.50)%
Earnings
(43.27)%
5.41%
(141.50)%
Dividends
- -
- -
- -
Book value
12.91%
21.84%
12.77%
Insider Trading
Type
Shares
Date
North Michael Paul
Sale
5,908
03/03/23
Bohnert Denise M.
Award
2,725
02/23/23
Bohnert Denise M.
Award
2,876
02/23/23
Bohnert Denise M.
Award
1,363
02/23/23
Muscato Nick
Award
2,725
02/23/23
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
492
485
544
551
2,072
2021
537
564
553
559
2,214
2022
545
558
558
562
2,223
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
0.98
1.06
2.21
1.39
5.64
2021
1.53
2.46
1.38
1.05
6.42
2022
0.97
0.91
0.79
0.97
3.64
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Medical Care Facilities
CEO:
Mr. Paul Berthold Kusserow
Full-time employees:
21,000
City:
Baton Rouge
Address:
3854 American Way
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.